Financial Forecast: Investment Opportunities and Trends in the Booming Pet Care Industry
The pet care industry gets described as "booming" in roughly every press release that crosses my desk, and the word does the same job every time: it lets the writer skip the numbers. So here are the numbers. The US pet industry was worth about $158 billion in 2024 and is projected near $165 billion in 2026, according to the American Pet Products Association. The global market sits around $280 billion in 2026, growing roughly 7% a year. That is real money, and where there is real money there are people deciding what happens to it — usually well upstream of the shelf you shop on. This is a look at who those people are, where they are putting capital in 2026, and what it actually means if you are thinking about investing in the pet industry yourself.
What the pet care market is actually worth
Start with the primary source everyone else cites and few of them name plainly. The APPA puts 2024 US spending at $158 billion, and its own segment breakdown tells you where it goes: pet food and treats account for $68.3 billion — about 43% of the whole — followed by vet care and product sales at $41.0 billion, supplies and live animals and OTC medications at $34.4 billion, and other services at $14.3 billion.
Globally the picture is bigger and the estimates disagree, which is normal and worth saying out loud. Fortune Business Insights pegs the global pet care market at $280 billion in 2026, rising to $394 billion by 2031 at a 7.1% compound annual growth rate. Future Market Insights runs a longer ruler and lands at $243.5 billion in 2025 climbing to $483.5 billion by 2035, also at 7.1%. Different base years, different end points, same growth rate — when independent firms converge on a number like 7%, you can lean on it. North America held about 42.9% of global revenue in 2025, so the US figures above are not a footnote to the world market; they are close to half of it.
The reason the demand holds up is not complicated and it is not new: 69% of Millennials and Gen Z say they consider their pets family members. People do not cut the family budget first. That is the entire investment thesis in one sentence — and it is why pet spending is treated as recession-resilient by the firms now buying into it.
Where the growth actually is
"The pet care market is growing" is true and useless. The growth is not evenly spread, and the segments pulling ahead are the ones worth watching.
Pet insurance is the fastest-growing money sub-vertical, and also the one I would read the fine print on hardest. Estimates put the 2026 market somewhere between $14.85 billion and $17.59 billion depending on whose report you buy. Mordor Intelligence projects it reaching $29.94 billion by 2031 at an 11.23% CAGR; Coherent Market Insights runs hotter, $41.45 billion by 2033 at 15.8%. The growth is genuine. So is the gap between how fast people are enrolling and how well they understand what a reimbursement policy actually covers — which is a risk for the category, not just for the policyholder.
Fresh and direct-to-consumer food is the other standout. Refrigerated and frozen dog food sales grew 13.4% while the total dog-food category was flat at -0.2%. The DTC pet-food market specifically was about $3.66 billion in 2025 and is projected to hit $22.8 billion by 2035 at roughly 20.2% annually. That is the steepest curve in this whole piece.
Veterinary care is the segment most quietly changing ownership — and it is my own beat, so I will be specific. Corporations and private-equity firms now control an estimated 30% to 50% of US vet clinics, up from roughly one in ten in 2010, after deploying more than $50 billion into the sector between 2017 and 2023. The signs on the buildings usually do not change. The owners behind them do: NVA runs 1,400-plus hospitals under JAB Holding, Thrive Pet Healthcare runs about 380 clinics under TSG Consumer, and Mars owns Banfield, BluePearl, and VCA. If you are evaluating "the pet care industry" as an investment, recurring, recession-resilient vet revenue is the reason the smart money got there first.
Pet care M&A in 2026: the consolidation thesis
The original version of this article called it "a flurry of mergers." Here is the flurry with numbers attached. The sector recorded about 532 transactions over the trailing twelve months into 2026 — a 41% jump on the prior year — and invested capital in Q2 2025 spiked to roughly $5.6 billion. Analysts have started calling it the paws-solidation era, which is a worse pun than the deals deserve.
The named deals are what matter, because every one of them tells you who now owns a brand you might recognize:
- Bansk Group acquired pet-wellness maker PetIQ for $1.5 billion
- Patient Square Capital acquired veterinary and dental distributor Patterson Companies for $4.1 billion
- Blackstone took over pet-services marketplace Rover Group for $2.3 billion
- General Mills bought Whitebridge Pet Brands for $1.4 billion in late 2024
- Partners Group acquired UK pet-food maker MPM Products for $539 million in September 2025
(deal details via GlobalPETS.) The pattern is the point: private equity and strategic consumer giants are buying the brands, the distributors, and the clinics. When you next buy a pet product, the parent company is increasingly likely to be a fund.
The disappearing middle: investing at both ends
The most useful 2026 trend for an investor is not a single rising tide — it is a split. As inflation squeezes budgets, about two-thirds of consumers have cut pet spending, private-label unit sales grew 3.5% in 2024–2025 while national brands fell 0.6%. Affluent owners keep premiumizing; everyone else trades down to value tiers. The middle is hollowing out.
That reframes the whole question. The opportunity is not "the pet industry." It is either the premium end — fresh food, insurance, specialty vet care for people who will not economize on a family member — or the value end, private label and discount channels, where volume is growing precisely because budgets are tight. A bet on the comfortable middle is a bet on the part of the market that is shrinking.
Pet tech as a vertical
The original article had a vague section on "emerging tech startups in finance and banking." There is a real vertical underneath that vagueness, and it has a number: the global pet-tech market is projected to grow from about $19.1 billion in 2026 to $52.9 billion by 2035, roughly 12% a year. That covers monitoring devices, telehealth, practice-management software, and the payment and subscription rails underneath the DTC food brands above. The fintech-for-pet-business angle is real but thin on hard data — treat it as embedded payments and subscription billing riding on the DTC growth, not as its own sized market, because nobody has credibly sized it yet. When a category has no number, that absence is information too.
How to read a pet-industry pitch
So you have a pitch in front of you — a fund, a DTC brand, a vet roll-up, a pet-tech app. Three questions get you most of the way:
Who is the parent company, and do they disclose it? Consolidation means the brand on the box is often not the entity making the decisions. Find the fund.
What is the actual recurring revenue? Insurance premiums and subscription food recur; one-time gadget sales do not. The recession-resilience thesis only holds for the recurring half.
And which end of the disappearing middle does this serve? Premium or value is a defensible answer in 2026. "The growing pet market" is not.
The booming pet care industry is real. So is the fact that most of the money decisions affecting your pet are now made by people you will never meet, in funds you have never heard of. The least you can do, before you invest a dollar or buy a bag, is ask whose dollar it already is.
Frequently Asked Questions
The strongest 2026 opportunities sit at the fast-growing ends of the market: pet insurance (11–16% annual growth), fresh and direct-to-consumer pet food (DTC growing ~20% a year), pet tech (~12% a year), and recession-resilient veterinary care, which is why private equity has been buying clinics aggressively. The shrinking part is the comfortable middle.
The US pet industry reached about $158B in 2024 and is projected near $165B in 2026 (APPA). The global market sits around $280B in 2026, growing roughly 7% annually toward $394–484B by the early-to-mid 2030s, with North America holding close to 43% of global revenue.
Pet insurance (~11–16% CAGR), fresh and direct-to-consumer pet food (DTC ~20% CAGR; refrigerated and frozen dog food +13.4% while the total category was flat), and pet tech (~12% CAGR) are the standout growth verticals, alongside ongoing veterinary consolidation.
Vet care offers recurring, recession-resilient demand. Corporations and PE firms now own an estimated 30–50% of US clinics, up from roughly 10% in 2010, having deployed over $50B into the sector from 2017–2023 through roll-up platforms like NVA, Thrive, and Mars-owned VCA and Banfield.
